Opportunity
Alberta Purchasing #AB-2026-02306
Award of Off-Patent Injectable Pharmaceutical Products for Alberta Hospitals
Posted
March 18, 2026
Identifier
AB-2026-02306
NAICS
424210, 325412
This award notice details the results of a major procurement for injectable pharmaceutical products in Alberta: - Government Buyer: - HealthPRO Procurement Services Inc. (main office: 360 Oakville Place, Suite 102, Oakville, Alberta, Canada) - OEMs and Vendors Awarded: - Avir Pharma Inc. - Fresenius Kabi - Hikma Canada Limited - Juno Pharma Canada Inc. - Pfizer Canada ULC - SteriMax Inc. - Products/Services Requested: - Off-patent, hospital-specific injectable pharmaceutical products - Used primarily by healthcare institutions - No specific part numbers or quantities listed - Notable Requirements: - Awards governed by trade agreements: NWPTA, CFTA, TCA, CETA - Total contract value: $161,360,254 - Place of performance: Alberta - Focus on injectable pharmaceuticals for hospital use
Description
HealthPRO Procurement Services Inc. has issued an award notice for the November 2025 Market Response RFP concerning off-patent, hospital-specific injectable pharmaceutical products primarily used by healthcare institutions. The total awarded contract value is approximately $161 million, distributed among multiple suppliers including Fresenius Kabi, SteriMax Inc., and others. The awards cover various injectable pharmaceutical products to be delivered in Alberta under trade agreements such as NWPTA, CFTA, TCA, and CETA. Contact for this opportunity is Stephanie Buonincontro at HealthPRO Canada.